A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma
Phase of Trial: Phase II
Latest Information Update: 10 Oct 2016
Price : $35 *
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Lipoma
- Focus Therapeutic Use
- 08 May 2014 Primary endpoint 'Tumour-volume' has been met as reported in a Biospecifics Technologies Corp media release.
- 04 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Oct 2013 New trial record